Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 3 studies | 32% ± 9% | |
| glutamatergic neuron | 3 studies | 46% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 29% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 2251.00 | 2604 / 2642 | 68% | 5.39 | 482 / 705 |
| pancreas | 78% | 275.33 | 257 / 328 | 67% | 3.83 | 119 / 178 |
| lung | 63% | 212.73 | 362 / 578 | 67% | 5.57 | 775 / 1155 |
| breast | 53% | 357.86 | 243 / 459 | 68% | 5.66 | 757 / 1118 |
| kidney | 56% | 214.39 | 50 / 89 | 57% | 3.69 | 517 / 901 |
| spleen | 100% | 591.91 | 241 / 241 | 0% | 0 | 0 / 0 |
| ovary | 13% | 34.82 | 23 / 180 | 80% | 7.58 | 346 / 430 |
| uterus | 49% | 149.56 | 84 / 170 | 43% | 3.30 | 197 / 459 |
| lymph node | 0% | 0 | 0 / 0 | 79% | 4.46 | 23 / 29 |
| prostate | 55% | 199.78 | 135 / 245 | 23% | 0.78 | 114 / 502 |
| peripheral blood | 75% | 802.08 | 693 / 929 | 0% | 0 | 0 / 0 |
| thymus | 19% | 58.85 | 121 / 653 | 54% | 2.62 | 326 / 605 |
| esophagus | 22% | 68.69 | 321 / 1445 | 49% | 3.56 | 89 / 183 |
| bladder | 14% | 35.62 | 3 / 21 | 51% | 4.09 | 258 / 504 |
| adrenal gland | 40% | 150.55 | 103 / 258 | 25% | 1.65 | 58 / 230 |
| intestine | 20% | 69.03 | 194 / 966 | 36% | 2.27 | 192 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 47% | 3.00 | 21 / 45 |
| stomach | 5% | 15.65 | 19 / 359 | 40% | 2.39 | 114 / 286 |
| skin | 12% | 33.53 | 217 / 1809 | 27% | 1.58 | 126 / 472 |
| eye | 0% | 0 | 0 / 0 | 23% | 0.77 | 18 / 80 |
| heart | 18% | 51.85 | 152 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 17% | 1.28 | 68 / 406 |
| adipose | 4% | 14.15 | 54 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 15.45 | 56 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0046579 | Biological process | positive regulation of Ras protein signal transduction |
| GO_0007265 | Biological process | Ras protein signal transduction |
| GO_0016477 | Biological process | cell migration |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| Gene name | RASGEF1A |
| Protein name | RasGEF domain family member 1A Ras-GEF domain-containing family member 1A |
| Synonyms | |
| Description | FUNCTION: Guanine nucleotide exchange factor (GEF) with specificity for RAP2A, KRAS, HRAS, and NRAS (in vitro). Plays a role in cell migration. . |
| Accessions | Q8N9B8 H7BYA3 ENST00000395809.5 [Q8N9B8-1] ENST00000395810.6 [Q8N9B8-1] ENST00000374459.5 [Q8N9B8-2] ENST00000374455.2 |